ACT 4 Children shared a post on LinkedIn:
“Access to cancer medicines is essential, but quality is non-negotiable.
An investigation by The Bureau of Investigative Journalism highlights a deeply concerning issue: widely used cancer medicines circulating globally that do not consistently meet quality standards.
In laboratory testing across multiple countries, a significant share of chemotherapy drugs were found to contain too little or too much of the active ingredient. For children with cancer, the standard of care depends not only on availability, but on medicines working exactly as intended every time.
This is not about pointing fingers. It is about recognizing that medicine quality assurance is a core pillar of standard-of-care cancer treatment, alongside diagnosis, trained teams, and continuity of care.
At ACT 4 Children, we believe that ensuring children survive cancer requires more than expanding access – it requires strengthening regulatory systems, procurement standards, and global coordination so that medicines reaching hospitals are safe, effective, and reliable.
Children’s lives depend not just on treatment being available, but on it working as intended.”
More posts featuring ACT 4 Children.
